Kathleen Madden, FNP, MSN, AOCNP, APHN, discusses how to judiciously use steroids to manage adverse events in patients with melanoma who are receiving immunotherapy.
Kathleen Madden, FNP, MSN, AOCNP, APHN
Advertisement
Articles by Kathleen Madden, FNP, MSN, AOCNP, APHN
Kathleen Madden, FNP, MSN, AOCNP, APHN, discusses the nuances of immunotherapy related adverse events in melanoma.
Advertisement
Latest Updated Articles
Nuances of Immunotherapy-Related AEs in MelanomaPublished: February 14th 2020 | Updated:
Using Steroids to Manage Immunotherapy-Associated AEs in MelanomaPublished: March 30th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5